All Posts: cancer
-
Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T Therapy
A new, detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical presentation and pathologic features involved in a CAR-T related second cancer.
Category: News Release
-
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40
Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, and Amy Trentham-Dietz, PhD, of University of Wisconsin Carbone Cancer Center, were lead authors of a study informing the updated final recommendation of the United States Preventive Services Task Force regarding breast cancer screening, released April 30
Category: News Release
-
Psychosocial Oncology Program Promotes Cura Personalis in Cancer Care
As director of the psychosocial oncology program at Georgetown Lombardi, Kimberly M. Davis, PhD, supports the psychological needs of cancer patients, while also training future independent clinical researchers in the field.
Category: Lombardi Stories
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy. The research is now in a phase 2 clinical trial being tested in human patients.
Category: Lombardi Stories
-
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that resistance can be overcome.
Category: Lombardi Stories
-
Georgetown Lombardi Faculty Members Aim To Improve Lung Cancer Screening and Smoking Cessation Rates by Focusing on Equity in Care
Kathryn Taylor, PhD, professor of oncology, believes she can have no greater impact on reducing the burden of cancer than by focusing on the harms of tobacco use. The work she co-leads with Randi Williams, PhD, assistant professor of oncology, as part of the Lung Screening, Tobacco, and Health (LSTH) research lab at Georgetown University’s Lombardi Comprehensive Cancer Center is especially impactful on underserved communities, who are often the target of tobacco product marketing.
Category: Lombardi Stories
-
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
With an emphasis on early-onset gastrointestinal cancer, the 14th Annual Ruesch Center Symposium brought together nearly 300 health care providers, researchers, advocates, patients and caregivers November 16-18 to honor those dedicated to curing GI cancers, discuss the experiences of patients and caregivers, and share the latest research in the field.
Category: Lombardi Stories
-
Computer Models Fill Critical Knowledge Gaps To Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to a new, wide-ranging perspective by researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues. A collection of new studies in the November 8, 2023, special issue of JNCI devoted to cancer disparities modeling outlines a path forward.
Category: News Release
-
Atkins Inducted as Academy of Immuno-Oncology Fellow
The Society for Immunotherapy of Cancer (SITC) has inducted Georgetown Lombardi Deputy Director Michael B. Atkins, MD, as a Fellow of the Academy of Immuno-Oncology (FAIO). The 2023 class was inducted November 3 at the SITC’s 38th Annual Meeting in San Diego.
Category: Lombardi Stories
-
Tobacco Regulations Center Receives $20 Million for Tobacco Use Research
The Center for the Assessment of Tobacco Regulations (CAsToR) — a collaboration with Georgetown University, the University of Michigan, and the British Columbia (BC) Cancer Research Institute — recently received $20 million in funding to continue its research on the impact of tobacco regulations on tobacco use patterns and their downstream health effects.
Category: News Release